NCT01478438

A Multicenter "Ablate and Resect" Study of Novilase® Interstitial Laser Therapy for the Ablation of Small Breast Cancers

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 60 (estimated)
• Sponsor: Novian Health Inc. · Industry
• Sex: Female
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

This study will determine the rate of complete tumor ablation of small breast cancers (≤ 20mm) by Novilase Interstitial Laser Therapy (ILT), and determine the sensitivity and specificity of imaging (MRI, mammography and ultrasound) in detecting residual tumor post ILT ablation as correlated to histopathology from the post-ablation excision.

Conditions

• Malignant Tumor

Interventions

Type	Name	Description
DEVICE	Novilase Interstitial Laser Therapy	Image guided Interstitial Laser Ablation of breast tumors

Timeline

• Start date: 2012-04-01
• Primary completion: 2015-12-01
• Completion: 2021-08-01
• First posted: 2011-11-23
• Last updated: 2021-03-03

Locations

12 sites across 2 countries: United States, United Kingdom